In Vitro and in Vivo Activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor Against Endometrial Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2867-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Erratum To: In Vitro and in Vivo Activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor Against Endometrial Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Evaluation of Locked Nucleic Acid-Modified Small Interfering RNA in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Hybridization-Based Detection of Helicobacter Pylori at Human Body Temperature Using Advanced Locked Nucleic Acid (LNA) Probes

PLoS ONE
Multidisciplinary
2013English

Computational Investigation of Locked Nucleic Acid (LNA) Nucleotides in the Active Sites of DNA Polymerases by Molecular Docking Simulations

PLoS ONE
Multidisciplinary
2014English

Allometric Scaling Approaches for Predicting Human Pharmacokinetic of a Locked Nucleic Acid Oligonucleotide Targeting Cancer-Associated miR-221

Cancers
Cancer ResearchOncology
2019English

Clinical Relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Activity of Azithromycin Against Leishmania Major in Vitro and in Vivo.

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2002English

Antitumor Activity of the Selective Cyclooxygenase-2 Inhibitor, Celecoxib, on Breast Cancer in Vitro and in Vivo

Cancer Cell International
Cancer ResearchOncologyGenetics
2012English

Inhibitor of Endocannabinoid Deactivation Protects Against in Vitro and in Vivo Neurotoxic Effects of Paraoxon

Journal of Molecular Neuroscience
MedicineMolecular NeuroscienceCellular
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy